Maike Trommer

University of Cologne, University Hospital Cologne

Papers

3

Total Citations

87

H-Index

3

About

Maike Trommer is a radiation oncologist whose research focuses on the intersection of advanced radiotherapy techniques and immunotherapy, particularly in the treatment of metastatic and oligometastatic cancers. Her major contributions include pioneering work on combining robotic stereotactic radiosurgery with immune checkpoint inhibitors, as demonstrated in her most-cited study on melanoma patients with brain metastases receiving simultaneous anti-PD-1 treatment (45 citations). This work helped clarify imaging findings, acute toxicity, and local control outcomes in a rapidly evolving treatment paradigm. Trommer also advanced the use of stereotactic body radiation therapy (SBRT) for adrenal metastases in oligometastatic non-small cell lung cancer (29 citations), providing critical efficacy and toxicity data that supports SBRT as a viable alternative to surgery. Additionally, her long-term results on robotic radiosurgery for cervical cancer patients unsuitable for brachytherapy (13 citations) offer an important salvage or alternative treatment strategy. Through these studies, Trommer has demonstrated how precision radiation technologies can be safely integrated with systemic therapies to improve outcomes in challenging patient populations, making her a key contributor to the field of stereotactic radiosurgery and immuno-radiotherapy.

Research Focus

Key Achievements

3
H-Index
3
Papers
87
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment
45 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Cologne, University Hospital Cologne

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago